Alphatec CEO sells $2.42M worth of stock on the heels of strong Q2

Spinal Tech

Patrick Miles, CEO of Alphatec, sold 180,000 shares of the company for about $2.42 million, Seeking Alpha reported Sept. 20.

The sales were disclosed in an SEC filing and reported pursuant to a Rule 10b5-1 trading plan, the report said.

Mr. Miles' stock sale comes just over a month after the company reported $177 million second quarter revenue, a 39 percent increase year-over-year. The company also saw a banner year in 2022 with a 44 percent revenue jump.

This year, Alphatec is expecting its 2023 revenue to grow 32 percent year-over-year.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers